Sedative
PreclinicalSmall molecule
Sedative is one of 36 small molecule programs targeting Sedation. It is currently in Preclinical.
3
Indications
4
Total Trials
2
Active Trials
35
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
52 competitors in Sleep Apnea
#DrugCompanyPhaseTrials
1Diamox
TevaApproved
Aricept
EisaiApproved
Victoza
Novo NordiskApproved
Raldesy
PPragma
Approved
Lunesta
Akero TherapeuticsApproved
Propecia
OOrganon and Co
Approved
Protonix
WWyeth-Lederle Vaccines
Approved
Oxycontin
PProtega
Approved
Ultram
WWim Janssens
Approved
Nuvigil
NNuvo Research GmbH
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sleep Apnea1 trial
Combination Therapy to Treat Sleep Apnea
Completed·—·N/A·NCT01633827·22 enrolled
Effectiveness1 trial
"Comparison of the Effectiveness of Conventional Radiofrequency Thermocoagulation and Chemical Ablation With Phenol on Articular Branches of Femoral and Obturator Nerves in Chronic Hip Pain"
Not yet recruiting·—·N/A·NCT06570746·48 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Sedative. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details